Helena Nordin Rudberg
Chief Executive Officer at Crane Ridge Pharma Consulting AB
Helena Nordin Rudberg active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Crane Ridge Pharma Consulting AB | Chief Executive Officer | - | - |
| Chairman | - | - | |
| Reyholmia AB | Director/Board Member | - | - |
| Swedish Investment Development Organization AB | Director/Board Member | - | - |
Career history of Helena Nordin Rudberg
Former positions of Helena Nordin Rudberg
| Companies | Position | Start | End |
|---|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | - | - |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Sales & Marketing | - | - |
| SERENDEX PHARMACEUTICALS A/S | Director/Board Member | 2014-04-21 | - |
Statistics
International
| Sweden | 6 |
| Denmark | 2 |
Operational
| Director/Board Member | 3 |
| Chief Executive Officer | 1 |
| Chairman | 1 |
Sectoral
| Health Technology | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| Private companies | 5 |
|---|---|
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
Serendex Pharmaceuticals A/S
 Serendex Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Serendex Pharmaceuticals A/S engages in the research and development of pharmaceuticals for respiratory conditions. It develops drugs to treat respiratory conditions such as Pulmonary Alveolar Proteinosis, Bronchiectasis, Cystic Fibrosis related lung infections and Diffuse Alveolar Hemorrhage. The company was founded by Lars Heslet on October 31, 2008 and is headquartered in Horsholm, Denmark. | Health Technology |
| Crane Ridge Pharma Consulting AB | |
| Reyholmia AB | |
| Swedish Investment Development Organization AB |
